Intergenerational immune interactions: Malaria and maternal microchimerism

Microchimerism refers to the acquisition of foreign cells or DNA by an individual; maternal microchimerism (MMc) specifically refers to the in utero acquisition of maternal cells or DNA by the fetus [1]. MMc is a part of normal human pregnancy, can be detected as early at the second trimester [2] and is distributed both in hematopoietic cells and in the organs of the body [1, 3–5]. Cross-sectional work has demonstrated that MMc is readily detectable for decades after birth [6], suggesting that maternal cells are maintained long-term in the offspring. In addition, the acquisition of MMc is associated with the development of maternal antigen-specific tolerance [7]. The evolutionary benefit of maintaining these cells is unknown, although work from a mouse model suggests that they may confer protection from future pregnancy loss in the offspring [8].

Microchimerism has been studied within the context of solid organ and hematopoietic cell transplant [9–12], autoimmune disease [13–18], breast cancer [19–21] and abnormal pregnancy [22–24]. However, relatively little work has been done exploring the intersection of MMc and infectious disease.

To view restricted content, please:

Leave A Comment